Tempus AI Just Priced a $400 Million Debt Deal. Here’s What Investors Need to Watch

Tempus AI locked in an upsized $400 million private sale of 0% convertible senior notes maturing in 2032, opting to swap out secured borrowings for debt with no periodic interest as it sharpens its focus on healthcare data and diagnostics. The deal, raised from the original $350 million, is slated for a May 12 close. Tempus plans to use the proceeds to pay off $307.7 million in loans, cover roughly $27.2 million for capped-call hedges, and for general corporate purposes.

Artificial Intelligence · NASDAQ:TEMP · Stock Market
Tempus AI Stock Falls After USC Deal, Putting Its Cancer Data Push To The Test

Tempus AI Stock Falls After USC Deal, Putting Its Cancer Data Push To The Test

Tempus AI, Inc. on Thursday announced it's teaming up with the Keck School of Medicine of USC and Keck Medicine of USC, setting the stage for its molecular testing, AI-powered care-gap analysis, and trial-matching tools to roll out across a major Southern California health system. The deal brings these technologies to USC Norris Comprehensive Cancer Center, Keck Hospital of USC, USC Verdugo Hills, plus other USC hospitals and clinics.
23 April 2026
··
Follow on Google News
Add as preferred source Open in Google News

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Kodiak Gas Services

NYSE:KGS • Energy infrastructure 88/100 • ★★★★☆
#2 STRONG BUY

Neurocrine Biosciences

NASDAQ:NBIX • Healthcare 87/100 • ★★★★☆
#3 STRONG BUY

Alphabet Class A

NASDAQ:GOOGL • Communication services 85/100 • ★★★★☆
#4 BUY ON WEAKNESS

Applied Materials

NASDAQ:AMAT • Semiconductor equipment 84/100 • ★★★★☆
#5 ACCUMULATE

JPMorgan Chase

NYSE:JPM • Financials 80/100 • ★★★★☆
View full portfolio
Editorial model selection. Not personalised advice.